Zachary Crouch

Zachary Crouch has a diverse work experience that spans over two decades. Zachary started their career in 1998, where they gained valuable experience growing up, rolling their sleeves up and taking on various responsibilities. In 2004, they worked as a pharmacist at CVS Caremark Corporation until 2011. In 2009, they joined Johnson & Johnson as a Global Medical Safety Post Doctoral Fellow, a position they held until 2010. In 2010, they became an Oncology Marketing Post Doctoral Fellow at OSI Pharmaceuticals, where they worked until 2011.

From 2011 to 2017, Zachary worked at Seattle Genetics as a Commercial Strategy & Marketing professional. During their time there, they led the Adcetris Marketing Team and was responsible for all commercial activities associated with Adcetris in the US and Canada, achieving significant sales growth.

Since 2017, Zachary has been employed at Blueprint Medicines. Zachary has held several key roles, including Director, Brand Lead BLU-285, where they played an integral part in establishing the company's commercial organization. Zachary then served as the Senior Director, Global Brand Lead for AYVAKIT, leading the US cross-functional launch execution and commercial strategy development for KIT precision therapies. From 2021 to 2022, they worked as the Senior Director, International Operations, driving commercial and lifecycle strategy in European markets and supporting Blueprint Medicines' geographic expansion. Currently, they hold the position of Vice President, Therapeutic Area Lead, where they utilize their leadership skills to oversee therapeutic areas within the company.

Overall, Zachary Crouch's work experience demonstrates their expertise in commercial strategy, marketing, and pharmaceutical development.

Zachary Crouch received their Pharm.D. degree from Rutgers University between 2003 and 2009. In 2018, they also completed an Executive Education program at Columbia Business School, focusing on Finance and Accounting for Executives.